NEW DELHI, Jan 18 (NNN-PTI) – A total of 447 cases of Adverse Event Following Immunisation (AEFIs), after the COVID-19 vaccination, have been reported over the past two days, out of whom three required hospitalisation, India’s health ministry said yesterday.
“Of those who were hospitalised, one was discharged from the Northern Railway Hospital in Delhi, within 24 hours, one other was discharged from the All-India Institute of Medical Sciences (AIIMS) in Delhi, and one is still under observation in AIIMS, in Rishikesh (northern state of Uttarakhand) and is being monitored,” said a statement issued by the ministry.
Most of the AEFIs reported so far included minor ailments like fever, headache and nausea etc.
Till yesterday a total of 224,301 beneficiaries have been vaccinated, out of whom 17,072 beneficiaries were vaccinated yesterday alone.
The second day of the countrywide COVID-19 vaccination programme was conducted with 553 sessions held in six states.
An AEFI is any unexpected medical occurrence, following immunisation, which may not be related to vaccine or vaccination process. Protocols are in place for reporting, immediate case management at vaccination session site, transportation and hospitalisation and further care of such cases.
According to health ministry officials, protocols are also in place for systematic investigation and causality assessment of serious AEFIs.
All states have been advised to plan COVID-19 vaccination sessions, four days in a week, to minimise disruption of the routine health services. Some states have already publicised their weekly vaccination days.
Two types of COVID-19 vaccines were supplied for the vaccination drive. While the “Covishield” vaccine, made by the Serum Institute of India, was supplied to all states, the “Covaxin” vaccine, made by Bharat Biotech International Limited, was supplied to 12 states.– NNN-PTI
